Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Effect of Dual Blockade of the Renin-Angiotensin System on the Progression of Type 2 Diabetic Nephropathy: A Randomized Trial
Gema Fernández Juárez, José Luño, V. Barrio, et al.
American Journal of Kidney Diseases (2012) Vol. 61, Iss. 2, pp. 211-218
Closed Access | Times Cited: 81

Showing 1-25 of 81 citing articles:

KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease
Alfred K. Cheung, Tara I. Chang, William C. Cushman, et al.
Kidney International (2021) Vol. 99, Iss. 3, pp. S1-S87
Open Access | Times Cited: 940
Renin-Angiotensin System Inhibitors and Kidney and Cardiovascular Outcomes in Patients With CKD: A Bayesian Network Meta-analysis of Randomized Clinical Trials
Xinfang Xie, Youxia Liu, Vlado Perkovic, et al.
American Journal of Kidney Diseases (2015) Vol. 67, Iss. 5, pp. 728-741
Open Access | Times Cited: 370
ACE Inhibitor Benefit to Kidney and Cardiovascular Outcomes for Patients with Non-Dialysis Chronic Kidney Disease Stages 3–5: A Network Meta-Analysis of Randomised Clinical Trials
Yaru Zhang, Dandan He, Wei Zhang, et al.
Drugs (2020) Vol. 80, Iss. 8, pp. 797-811
Open Access | Times Cited: 139
Sodium–glucose linked transporter-2 inhibitors: potential for renoprotection beyond blood glucose lowering?
Richard E. Gilbert
Kidney International (2013) Vol. 86, Iss. 4, pp. 693-700
Open Access | Times Cited: 107
Clinical Challenges in Diagnosis and Management of Diabetic Kidney Disease
Robert C. Stanton
American Journal of Kidney Diseases (2014) Vol. 63, Iss. 2, pp. S3-S21
Open Access | Times Cited: 96
Therapeutic Insights in Chronic Kidney Disease Progression
Amir Shabaka, Clara Cases‐Corona, Gema Fernández‐Juárez
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 62
25 (OH) Vitamin D Levels and Renal Disease Progression in Patients with Type 2 Diabetic Nephropathy and Blockade of the Renin-Angiotensin System
Gema Fernández‐Juárez, José Luño, V. Barrio, et al.
Clinical Journal of the American Society of Nephrology (2013) Vol. 8, Iss. 11, pp. 1870-1876
Open Access | Times Cited: 89
The association between dual RAAS inhibition and risk of acute kidney injury and hyperkalemia in patients with diabetic kidney disease: a systematic review and meta-analysis
Reid Whitlock, Silvia J. Leon, Hazel Manacsa, et al.
Nephrology Dialysis Transplantation (2023) Vol. 38, Iss. 11, pp. 2503-2516
Open Access | Times Cited: 17
EMPA-REG OUTCOME: The Nephrologist's Point of View
Christoph Wanner
The American Journal of Medicine (2017) Vol. 130, Iss. 6, pp. S63-S72
Open Access | Times Cited: 56
EMPA-REG OUTCOME: The Nephrologist's Point of View
Christoph Wanner
The American Journal of Cardiology (2017) Vol. 120, Iss. 1, pp. S59-S67
Open Access | Times Cited: 52
Efficacy and Safety of Dual Blockade of the Renin–Angiotensin–Aldosterone System in Diabetic Kidney Disease: A Meta-Analysis
Yanhuan Feng, Rongshuang Huang, Janet Kavanagh, et al.
American Journal of Cardiovascular Drugs (2019) Vol. 19, Iss. 3, pp. 259-286
Closed Access | Times Cited: 48
Progression of diabetic kidney disease in T2DN rats
Oleg Palygin, Denisha Spires, Vladislav Levchenko, et al.
AJP Renal Physiology (2019) Vol. 317, Iss. 6, pp. F1450-F1461
Open Access | Times Cited: 44
Comparative effectiveness of traditional Chinese medicine and angiotensin converting enzyme inhibitors, angiotensin receptor blockers, and sodium glucose cotransporter inhibitors in patients with diabetic kidney disease: A systematic review and network meta-analysis
Lili Zhang, Runyu Miao, Tongyue Yu, et al.
Pharmacological Research (2022) Vol. 177, pp. 106111-106111
Closed Access | Times Cited: 24
Renoprotective Effect of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers in Diabetic Patients with Proteinuria
Feng-Yi Hsu, Fang‐Ju Lin, Huang‐Tz Ou, et al.
Kidney & Blood Pressure Research (2017) Vol. 42, Iss. 2, pp. 358-368
Open Access | Times Cited: 47
Combination use of medicines from two classes of renin–angiotensin system blocking agents: risk of hyperkalemia, hypotension, and impaired renal function
Raquel Esteras, María Vanessa Pérez-Gómez, Laura Rodríguez-Osorio, et al.
Therapeutic Advances in Drug Safety (2015) Vol. 6, Iss. 4, pp. 166-176
Open Access | Times Cited: 45
Effects of ACEIs Versus ARBs on Proteinuria or Albuminuria in Primary Hypertension
Rui Xu, Shanmei Sun, Yan Huo, et al.
Medicine (2015) Vol. 94, Iss. 39, pp. e1560-e1560
Open Access | Times Cited: 45
Angiotensin-converting-enzyme inhibitors and angiotensin receptor blockers for preventing the progression of diabetic kidney disease
Patrizia Natale, Suetonia C. Palmer, Sankar D. Navaneethan, et al.
Cochrane library (2024) Vol. 2024, Iss. 5
Closed Access | Times Cited: 4
Assessing the Validity of Surrogate Outcomes for ESRD
Min Jun, Tanvir Chowdhury Turin, Mark Woodward, et al.
Journal of the American Society of Nephrology (2015) Vol. 26, Iss. 9, pp. 2289-2302
Open Access | Times Cited: 40
Meta-analysis: the efficacy and safety of combined treatment with ARB and ACEI on diabetic nephropathy
Feifeng Ren, Lin Tang, Yin Cai, et al.
Renal Failure (2015) Vol. 37, Iss. 4, pp. 548-561
Open Access | Times Cited: 39
Present and Future in the Treatment of Diabetic Kidney Disease
Borja Quiroga, David Arroyo, Gabriel de Arriba
Journal of Diabetes Research (2015) Vol. 2015, pp. 1-13
Open Access | Times Cited: 38
Clinical Practice Guideline for detection and management of diabetic kidney disease: A consensus report by the Spanish Society of Nephrology
Núria Montero, Laia Oliveras, Alberto Martínez‐Castelao, et al.
Nefrología (English Edition) (2025) Vol. 45, pp. 1-26
Open Access
Vitamin D and proteinuria: a critical review of molecular bases and clinical experience.
María Vanessa Pérez-Gómez, Alberto Ortíz, Víctor Lorenzo-Sellares
PubMed (2013) Vol. 33, Iss. 5, pp. 716-26
Closed Access | Times Cited: 33
New Insight into the Molecular Drug Target of Diabetic Nephropathy
Vivian Soetikno, Wawaimuli Arozal, Melva Louisa, et al.
International Journal of Endocrinology (2014) Vol. 2014, pp. 1-9
Open Access | Times Cited: 30
Effects of dual blockade of the renin–angiotensin system on renal and cardiovascular outcomes in type 2 diabetes with overt nephropathy and hypertension in the ORIENT: a post-hoc analysis (ORIENT–Hypertension)
Enyu Imai, Masakazu Haneda, Tetsu Yamasaki, et al.
Hypertension Research (2013) Vol. 36, Iss. 12, pp. 1051-1059
Open Access | Times Cited: 28
Urinary Dickkopf-3: a new biomarker for CKD progression and mortality
Beatriz Sánchez‐Álamo, Francisco José García-Iñigo, Amir Shabaka, et al.
Nephrology Dialysis Transplantation (2021) Vol. 36, Iss. 12, pp. 2199-2207
Open Access | Times Cited: 20
Page 1 - Next Page

Scroll to top